Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Healthcare

Daily deal net: October 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: October 11, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Pyxis progresses to stock market
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
Daily deal net: October 7, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Exscientia expands IPO to over $350m
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
Daily deal net: October 6, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Exo Therapeutics bags $78m
The small molecule drug developer has raised a series B round that brought its total funding to more than $100m.
Pyxis picks price range
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

Other News

Daily deal net: October 4, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Exscientia establishes Nasdaq listing
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Micreos makes space for $37.5m
Exploiting ETH Zurich research, Micreos is working on a clinical platform that enables the targeted killing of unwanted bacteria only.
Daily deal net: September 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
HSU and UC Davis launch tech centre
Humboldt State University has joined forces with UC Davis to create an incubator focused on agtech and biotech companies in northern California.

Editor's Picks

Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login